PRSS1 mutations were present in 68% (78% R122H, 12% N29I, 10% others) of the study cohort and again the PRSS1 mutation type did not correlate with the development of pancreatic cancer, which was diagnosed in ten individuals at a median age of 55. Here, PRSS1 is linked to pancreatic neoplasm.